Merck & Co (MRK) net assets (shareholders' equity)

Net assets · fiscal 2025
$52.61B

Merck & Co (MRK) had net assets of $52.61B at the end of fiscal 2025 (December 31, 2025). That is 13.6% higher than the $46.31B of fiscal 2024. Figures as of 18 Nov 2026, 21:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$52.61B
Change on fiscal 2024
+13.6%
Growth, 5 years
+15.8% a year
Growth, 10 years
+1.6% a year
Highest on record
$59.06Bfiscal 2009
Lowest on record
$18.76Bfiscal 2008
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Merck & Co net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 15.8% a year; over ten years the rate was 1.6% a year. Across the 19 fiscal years on record (2007–2025), the highest was $59.06B in fiscal 2009 and the lowest $18.76B in fiscal 2008.

History · 19 fiscal years

Net assets by fiscal year

Merck & Co net assets (shareholders' equity), year by year

Merck & Co (MRK) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$52.61B 13.6% up
2024$46.31B 23.2% up
2023$37.58B 18.3% down
2022$45.99B 20.4% up
2021$38.18B 50.8% up
2020$25.32B 2.3% down
2019$25.91B 3.0% down
2018$26.70B 22.2% down
2017$34.34B 14.3% down
2016$40.09B 10.3% down
2015$44.68B 8.2% down
2014$48.65B 2.2% down
2013$49.77B 6.1% down
2012$53.02B 2.7% down
2011$54.52B 0.3% up
2010$54.38B 7.9% down
2009$59.06B 214.8% up
2008$18.76B 8.9% down
2007$20.59B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Merck & Co and comparable companies
CompanyNet assetsFiscal year
Johnson & Johnson JNJ$81.54B2025
AbbVie ABBV-$3.27B2025
Merck & Co MRK$52.61B2025
UnitedHealth Group UNH$94.11B2025
Novartis NVS$46.13B2025
AstraZeneca AZN$48.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MRK

Merck & Co, figure by figure

Merck & Co (MRK) overview: price, valuation and scorecardAll health care companies by market value

Merck & Co net assets (shareholders' equity): questions and answers

What are Merck & Co's net assets?

Merck & Co (MRK) had net assets of $52.61B at the end of fiscal 2025 (December 31, 2025). That is 13.6% higher than the $46.31B of fiscal 2024.

What is the growth rate of Merck & Co's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 15.8% a year; over ten years the rate was 1.6% a year.

What are the highest and lowest net assets figures on record for Merck & Co?

Across the 19 fiscal years on record (2007–2025), the highest was $59.06B in fiscal 2009 and the lowest $18.76B in fiscal 2008.

How is Merck & Co's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Merck & Co it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Merck & Co (MRK) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/MRK/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.